CCM
HZNP

Consonance Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Consonance Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,218,903
Closed -$91.9M – 27
2017
Q1 		$91.9M Buy
6,218,903
+425,000
+7% +$6.88M 9.63% 1
2016
Q4 		$93.7M Buy
5,793,903
+2,095,000
+57% +$38M 10.3% 2
2016
Q3 		$67.1M Buy
+3,698,903
New +$72.3M 6.45% 7
2013
Q4 		– Sell
-105,000
Closed -$352K – 29
2013
Q3 		$352K Buy
+105,000
New +$277K 0.09% 25

Other funds holding HZNP

SCM
Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return